H

Heartflow Inc
NASDAQ:HTFL

Watchlist Manager
Heartflow Inc
NASDAQ:HTFL
Watchlist
Price: 30.44 USD -2.56% Market Closed
Market Cap: $2.6B

EV/FCFF

0
Current
No historical data
Comparison unavailable

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
0
=
Enterprise Value
$0
/
Free Cash Flow to Firm
0

Enterprise Value to Free Cash Flow to Firm (EV/FCFF) ratio compares a company`s total enterprise value to the free cash flow available to all investors, both debt and equity holders. It shows how much investors are paying for each dollar of cash flow the business generates before interest payments.

EV/FCFF
0
=
Enterprise Value
$0
/
Free Cash Flow to Firm
0

Valuation Scenarios

Heartflow Inc is trading above its industry average

If EV/FCFF returns to its Industry Average (23), the stock would be worth $0 (100% downside from current price).

Statistics
Positive Scenarios
0/2
Maximum Downside
-100%
Maximum Upside
No Upside Scenarios
Average Downside
100%
Scenario EV/FCFF Value Implied Price Upside/Downside
Current Multiple 0 $30.44
0%
Industry Average 23 $0
-100%
Country Average 23.2 $0
-100%

Forward EV/FCFF
Today’s price vs future free cash flow to firm

Not enough data available to calculate forward EV/FCFF

Peer Comparison

All Multiples
EV/FCFF
P/E
All Countries
Close
Market Cap EV/FCFF P/E
US
Heartflow Inc
NASDAQ:HTFL
2.6B USD 0 0
JP
Medical Data Vision Co Ltd
TSE:3902
37.9T JPY 86.2 227.5
US
Cerner Corp
LSE:0R00
31.3B USD 28.3 53.1
US
Veeva Systems Inc
NYSE:VEEV
26.4B USD 14.2 29
AU
Pro Medicus Ltd
ASX:PME
14.5B AUD 118.7 61.6
JP
M3 Inc
TSE:2413
1T JPY 16.5 20.5
SE
Sectra AB
STO:SECT B
51.8B SEK 75.5 96.4
US
Waystar Holding Corp
NASDAQ:WAY
4.9B USD 21.7 42.4
US
Doximity Inc
NYSE:DOCS
4.4B USD 12.1 18.6
CN
Winning Health Technology Group Co Ltd
SZSE:300253
19.3B CNY 78.7 -62.7
US
Vocera Communications Inc
F:V00
2.4B EUR 66.3 -328
P/E Multiple
Earnings Growth PEG
US
H
Heartflow Inc
NASDAQ:HTFL
Average P/E: 68.6
Not Available
N/A N/A
JP
Medical Data Vision Co Ltd
TSE:3902
227.5
62%
3.7
US
C
Cerner Corp
LSE:0R00
53.1
N/A N/A
US
Veeva Systems Inc
NYSE:VEEV
29
27%
1.1
AU
Pro Medicus Ltd
ASX:PME
61.6
29%
2.1
JP
M3 Inc
TSE:2413
20.5
16%
1.3
SE
Sectra AB
STO:SECT B
96.4
14%
6.9
US
W
Waystar Holding Corp
NASDAQ:WAY
42.4
55%
0.8
US
Doximity Inc
NYSE:DOCS
18.6
15%
1.2
CN
Winning Health Technology Group Co Ltd
SZSE:300253
Negative Multiple: -62.7
69%
N/A
US
V
Vocera Communications Inc
F:V00
Negative Multiple: -328 N/A N/A

Market Distribution

Not Available
No Country distribution data available for this multiple

Heartflow Inc
Glance View

Market Cap
2.6B USD
Industry
Health Care

Heartflow Inc is a US-based company operating in Health Care Technology industry. The company is headquartered in Mountain View, California. The company went IPO on 2025-08-08. HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

HTFL Intrinsic Value
Not Available
H
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett